ClotCare: Blood Clots, Stroke, Heart Attack
Sunday, December 17, 2017
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

What Should we do About IM (Intramuscular) Injections for Warfarin-Treated Patients?

Henry I. Bussey, Pharm.D.
March, 2009

IM Injections should be avoided when the INR is supra-therapeutic but I'm not aware of studies evaluating IM Injections in patients with therapeutic INRs. Also, in our anticoagulation clinic, we continue to administer IM injections in warfarin-treated patients if the INR is not above the target range.

Various sources, however, indicate that flu vaccine, pneumovax, and other vaccinations can be administered subcutaneously with an adequate immune response. The CDC website (www.cdc.gov/FLU/about/qa/vaxadmin.htm), about half-way down the page, indicates that a dose of influenza vaccine given subcutaneously should be counted as an effective dose and not be re-administered. Also, the American Academy of Allergy and Immunology describe several studies in which subcutaneously administered immunizations were successful in inducing immunogenicity; and pneumovax is available for either intramuscular or subcutaneous (but not intradermal) injection (www.merck.com/product/usa/pi_circulars/
p/pneumovax_23/pneumovax_pi.pdf
).

If you have additional information or a different take on this issue, please feel free to submit your comments to Marie Walker at webmaster@clotcare.org.

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Questioning Approval of the Watchman Device for Atrial Fibrillation.

How Should We Prevent Blood Clots Following Arthroscopic Knee Surgery? Cynthia’s Story and a Limited Discussion of the Literature

Stroke, A Caregiver's Story

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to webmaster@clotcare.org.
Sunday, December 17, 2017